X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Press Statements

Joe Govier of Connect 2 Cleanrooms Ranked Among UK’s Top 50 Most Ambitious Business Leaders

Content Team by Content Team
29th October 2020
in Press Statements
Joe Govier of Connect 2 Cleanrooms Ranked Among UK's Top 50 Most Ambitious Business Leaders

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Joe Govier, CEO and Founder of Connect 2 Cleanrooms, has been named as one of LDC’s Top 50 Most Ambitious Business Leaders for 2020.

Now in its third year, the programme, which is supported by The Telegraph, celebrates the inspiring leaders behind some of the UK’s most successful and fast-growing medium-sized firms.

Connect 2 Cleanrooms was founded in 2002. Its turnover grew by 40% over the past year and Joe is now looking to expand his business into new international markets.

Joe says: “We crept into this market by doing small projects. Now we build multi-million-pound facilities for pharmaceutical and aerospace giants.

“Connect 2 Cleanrooms has grown through two recessions and a pandemic, all the while supporting my family and creating opportunities for the people who come and work here.

“We are extremely adaptable so we can flip to focus on sectors when confidence and growth is high. The opportunity is phenomenal.”

John Garner of LDC added: “The UK has a long-standing reputation for its entrepreneurial endeavour, but there has never been a more important time to recognise or back ambition in British business. The LDC Top 50 Most Ambitious Business Leaders aims to do just that. All of the inspiring leaders featured in our Top 50 this year have driven their business forward during a period of adversity, whether by expanding internationally, delivering real innovation, showcasing resilience or making a difference in their communities. They all deserve their place and I look forward to seeing their continued success.”

LDC is the UK’s leading mid-market private equity firm. Backed by Lloyds Banking Group, LDC is committed to investing £1.2bn over the next three years to support the ambitions of management teams leading mid-market businesses across the UK.

About Connect 2 Cleanrooms & Cleanroomshop

Connect 2 Cleanrooms is an integrated cleanroom solutions provider. Since 2002, the company has become a trusted partner to over 6000+ clients worldwide. Its range of cleanroom solutions deliver functional performance that meets precise requirements. Connect 2 Cleanrooms also provides cleanroom validation and training services. Its consumables division, Cleanroomshop, supplies a full portfolio of consumables, equipment and furniture to the cleanroom industry worldwide.

Vision Statement

To be internationally recognised as the industry innovator for critical environments. Proudly encouraging our people, clients and suppliers to be bold and enjoy the adventure of collaborative creativity whilst embracing growth, development and values.

Mission Statement

Protecting critical environments whilst creating a journey of development and innovation for all that we touch.

Previous Post

New Functionality Added to Thermo Scientific SampleManager LIMS software for Manufacturing QA/QC and Contract Laboratories

Next Post

MEDICAL FESTIVAL ASIA: New all-encompassing ecosystem comprising events for the region's medical and healthcare sector

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Pharma Advancement Banner
Press Statements

Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

27th June 2025
Next Post
MEDICAL FESTIVAL ASIA: New all-encompassing ecosystem comprising events for the region's medical and healthcare sector

MEDICAL FESTIVAL ASIA: New all-encompassing ecosystem comprising events for the region's medical and healthcare sector

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In